Liang Chen

Liang Chen

Auto-generated profile, based on publicly available information

Liang Chen

Department of Interventional and Vascular Radiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
ZLZhao-Xuan Lu
Zhao-Xuan Lu
BDBing-Qing Dong
Bing-Qing Dong
HWHeng-Le Wei
Heng-Le Wei
LCLiang Chen
Liang Chen
Background: The selection strategy of non-steroidal anti-inflammatory drugs (NSAIDs) for migraine is hard to judge whether it is effective, leading to unnecessary exposure to insufficient or lengthy treatment trials. The goal of the study was to investigate potential predictors of NSAIDs efficacy in migraine therapy and to explore their influence on efficacy.Methods: 610 migraine patients were recruited and assigned into responders and non-responders. Potential predictors among demographic and clinical characteristics for NSAIDs efficacy were extracted using multivariable logistic regression (LR) analysis, and were applied to construct prediction models via machine learning (ML) algorithms. Finally, Cochran-Mantel-Haenszel tests were used to examine the impact of each predictor on drug efficacy.Results: Multivariate LR analysis revealed migraine-related (disease duration, headache intensity and frequency) and psychiatric (anxiety, depression and sleep disorder) characteristics were predictive of NSAIDs efficacy. The accuracies of ML models using support vector machine, decision tree and multilayer perceptron were 0.712, 0.741, and 0.715, respectively. Cochran-Mantel-Haenszel test showed that, for variables with homogeneity of odds ratio, disease duration, frequency, anxiety, and depression and sleep disorder were associated with decreased likelihood of response to all NSAIDs. However, the variabilities in the efficacy of acetaminophen and celecoxib between patients with mild and severe headache intensity were not confirmed.Conclusion: Migraine-related and psychiatric parameters play a critical role in predicting the outcomes of acute migraine treatment. These models based on predictors could optimize drug selection and improve benefits from the start of treatment.

5 June 2025 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
ZLZhao-Xuan Lu
Zhao-Xuan Lu
BDBing-Qing Dong
Bing-Qing Dong
LCLiang Chen
Liang Chen
HWHeng-Le Wei
Heng-Le Wei
Migraine, a prevalent neurological disorder, is associated with dyslipidemia and increased cardiovascular morbidity; however, the prognostic value of lipid biomarkers, particularly the total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C) ratio, remains inadequately explored. This study aims to explore the potential relationship between the TC/HDL-C ratio and all-cause mortality in patients with migraine and determine optimal thresholds for prognostic prediction. Data from the 1999–2004 National Health and Nutrition Examination Surveys, encompassing 654 patients with migraine, were analyzed. A restricted cubic spline (RCS) was employed to delineate the dose-response relationship between the TC/HDL-C ratio and mortality risk. TC/HDL-C ratio was categorized into two groups based on thresholds derived from RCS and the maximally selected rank statistics method (MSRSM). Weighted multivariate Cox regression models were used to assess associations, adjusting for demographic variables, comorbidities, and inflammatory markers. Kaplan-Meier survival curves and time-dependent receiver operating characteristic (ROC) analysis were conducted to evaluate survival prognosis and prediction accuracy. Over a median follow-up of 16.33 years, 126 (19.27%) of the 654 patients died. RCS analysis revealed a U-shaped relationship between TC/HDL-C ratio and all-cause mortality. In the multivariable model, higher TC/HDL-C ratio (MSRSM-derived threshold of 5.15) were associated with a significantly increased risk of all-cause mortality (Hazard ratio = 2.986, 95% confidence interval = 1.495–5.967, p < 0.001), compared to the lower TC/HDL-C ratio cohort. Conversely, dichotomous stratification based on the RCS-derived inflection point (4.23) indicated no significance in the higher TC/HDL-C ratio group. Both two-piecewise linear regression and Kaplan–Meier survival curve analyses demonstrated significantly worse overall survival for the higher TC/HDL-C ratio cohort (≥ 5.15). Time-dependent ROC analysis revealed area under the curve of 0.865, 0.880, 0.891, and 0.889 for 5-, 10-, 15-, and 20-year survival rates, respectively, for all-cause mortality. This study reveals a nonlinear, U-shaped relationship between the TC/HDL-C ratio and all-cause mortality in patients with migraine, with higher TC/HDL-C ratio emerging as a robust, independent predictor of mortality. These findings underscore the potential of the TC/HDL-C ratio as a clinically actionable biomarker for personalized migraine management.

9 September 2022 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
ZLZhao-Xuan Lu
Zhao-Xuan Lu
HWHeng-Le Wei
Heng-Le Wei
YSYadong Shi
Yadong Shi
HHHao Huang
Hao Huang
HSHaobo Su
Haobo Su
LCLiang Chen
Liang Chen
Objective: This study investigates the safety and efficacy of endovascular treatments on pregnancy-related iliofemoral deep vein thrombosis (DVT). Methods: We retrospectively reviewed data of 46 patients who had symptomatic pregnancy-related iliofemoral DVT and underwent endovascular treatment. The patients treated with catheter-directed thrombolysis (CDT) were classified as the CDT group. In contrast, those treated with CDT combined with pharmacomechanical thrombectomy (PMT) or angioplasty/stenting were classified as the pharmacomechanical catheter-directed thrombolysis (PCDT) group. Results: Based on the immediate post-operative clot burden reduction rate analysis of 46 patients: 22 cases were completely dissolved (lysis grades III), 12 were partially dissolved (lysis grades II), and 12 failed (lysis grades I). There was a statistically significant difference in the rate of clot burden reduction between the CDT group (n = 19) and the PCDT group (n = 27) ( p = 0.001). There was no statistically significant difference in the number of bleeding events between the two groups ( p = 0.989). At 24 months, cumulative venous patency in the CDT group was 50.0%, compared to 78.2% in the PCDT group. Furthermore, there was a statistically significant difference in Villalta score (p = 0.001) and venous severity scoring (VCSS score) (p = 0.005) between the two groups. Conclusions: CDT treatment combined with PMT or angioplasty/stenting is comparatively safe and effective for pregnant-related DVT patients. PCDT outperforms CDT in terms of immediate efficacy and reduces the incidence of post-thrombotic syndrome with better midterm outcomes.

11 February 2026 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
ZLZhao-Xuan Lu
Zhao-Xuan Lu
BDBing-Qing Dong
Bing-Qing Dong
LCLiang Chen
Liang Chen
HWHeng-Le Wei
Heng-Le Wei
HZHong Zhang
Hong Zhang
Glycolipid dysregulation is a core driver of cardiometabolic multimorbidity (CMM), yet its role as an integrated network in CMM pathogenesis remains unexpl